118 related articles for article (PubMed ID: 26254420)
21. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
22. Restored expression of the MYO18B gene suppresses orthotopic growth and the production of bloody pleural effusion by human malignant pleural mesothelioma cells in SCID mice.
Edakuni N; Ikuta K; Yano S; Nakataki E; Muguruma H; Uehara H; Tani M; Yokota J; Aizawa H; Sone S
Oncol Res; 2006; 16(5):235-43. PubMed ID: 17294804
[TBL] [Abstract][Full Text] [Related]
23. Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.
Tsao AS; Harun N; Fujimoto J; Devito V; Lee JJ; Kuhn E; Mehran R; Rice D; Moran C; Hong WK; Shen L; Suraokar M; Wistuba I
Ann Diagn Pathol; 2014 Jun; 18(3):140-5. PubMed ID: 24747001
[TBL] [Abstract][Full Text] [Related]
24. A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.
Melaiu O; Cristaudo A; Melissari E; Di Russo M; Bonotti A; Bruno R; Foddis R; Gemignani F; Pellegrini S; Landi S
Mutat Res; 2012; 750(2):132-140. PubMed ID: 22198210
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation of apoptosis via the PARK7 interactome in peripheral blood mononuclear cells donated by tuberculosis patients vs. healthy controls and the response to treatment: A systems biology approach.
Vavougios GD; Zarogiannis SG; Krogfelt KA; Stamoulis G; Gourgoulianis KI
Tuberculosis (Edinb); 2020 Jul; 123():101938. PubMed ID: 32741527
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.
Hoang CD; D'Cunha J; Kratzke MG; Casmey CE; Frizelle SP; Maddaus MA; Kratzke RA
Chest; 2004 May; 125(5):1843-52. PubMed ID: 15136399
[TBL] [Abstract][Full Text] [Related]
27. Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma.
Hirayama N; Tabata C; Tabata R; Maeda R; Yasumitsu A; Yamada S; Kuribayashi K; Fukuoka K; Nakano T
Respir Med; 2011 Jan; 105(1):137-42. PubMed ID: 21041073
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma.
Lee HS; Hamaji M; Palivela N; Jang HJ; Splawn T; Ramos D; Lee AK; Raghuram AC; Ramineni M; Amos CI; Ripley RT; Burt BM
Ann Thorac Surg; 2021 Nov; 112(5):1575-1583. PubMed ID: 33248997
[TBL] [Abstract][Full Text] [Related]
29. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).
Baumunk D; Reichelt U; Hildebrandt J; Krause H; Ebbing J; Cash H; Miller K; Schostak M; Weikert S
World J Urol; 2013 Oct; 31(5):1191-6. PubMed ID: 22544372
[TBL] [Abstract][Full Text] [Related]
30. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
De Rienzo A; Richards WG; Yeap BY; Coleman MH; Sugarbaker PE; Chirieac LR; Wang YE; Quackenbush J; Jensen RV; Bueno R
Clin Cancer Res; 2013 May; 19(9):2493-502. PubMed ID: 23493352
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs dysregulation in human malignant pleural mesothelioma.
Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
[TBL] [Abstract][Full Text] [Related]
32. DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.
McNally RS; Davis BK; Clements CM; Accavitti-Loper MA; Mak TW; Ting JP
J Biol Chem; 2011 Feb; 286(6):4098-106. PubMed ID: 21097510
[TBL] [Abstract][Full Text] [Related]
33. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
[TBL] [Abstract][Full Text] [Related]
34. Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.
Kirschner MB; Pulford E; Hoda MA; Rozsas A; Griggs K; Cheng YY; Edelman JJ; Kao SC; Hyland R; Dong Y; László V; Klikovits T; Vallely MP; Grusch M; Hegedus B; Dome B; Klepetko W; van Zandwijk N; Klebe S; Reid G
Br J Cancer; 2015 Sep; 113(6):963-9. PubMed ID: 26263483
[TBL] [Abstract][Full Text] [Related]
35. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning.
Xiao Y; Huang W; Zhang L; Wang H
Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
Rena O; Boldorini LR; Gaudino E; Casadio C
J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
[TBL] [Abstract][Full Text] [Related]
37. The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.
Pignochino Y; Dell'Aglio C; Inghilleri S; Zorzetto M; Basiricò M; Capozzi F; Canta M; Piloni D; Cemmi F; Sangiolo D; Gammaitoni L; Soster M; Marchiò S; Pozzi E; Morbini P; Luisetti M; Aglietta M; Grignani G; Stella GM
BMC Cancer; 2015 May; 15():374. PubMed ID: 25952930
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.
Okuda K; Sasaki H; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1105-11. PubMed ID: 18392851
[TBL] [Abstract][Full Text] [Related]
39. Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
Gordon GJ; Rockwell GN; Godfrey PA; Jensen RV; Glickman JN; Yeap BY; Richards WG; Sugarbaker DJ; Bueno R
Clin Cancer Res; 2005 Jun; 11(12):4406-14. PubMed ID: 15958625
[TBL] [Abstract][Full Text] [Related]
40. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines.
Kuramitsu Y; Miyamoto H; Tanaka T; Zhang X; Fujimoto M; Ueda K; Tanaka T; Hamano K; Nakamura K
Proteomics; 2009 Nov; 9(22):5078-89. PubMed ID: 19771552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
